Global Albendazole Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Albendazole market size will reach 218.35 Million USD in 2025 and is projected to reach 379.58 Million USD by 2032, with a CAGR of 8.22% (2025-2032). Notably, the China Albendazole market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Albendazole is an anthelmintic medication used to treat a variety of parasitic worm infestations, including echinococcosis, cysticercosis, and neurocysticercosis. It works by preventing the worms from absorbing glucose, which ultimately leads to their death. Albendazole is available in tablet form and is commonly used in combination with other drugs for effective treatment.
The major global suppliers of Albendazole include GlaxoSmithKline, Huazhong Pharmaceutical, Jiangsu Qihui, Sequent Scientific, K.A. Malle Pharmaceuticals, Lasa Supergenerics Limited, Zhongjia Pharmaceutical, Fredun Pharmaceuticals Ltd, Salius Pharma, Supharma Chem, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Albendazole. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Albendazole market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Albendazole market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Albendazole industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Albendazole Include:
GlaxoSmithKline
Huazhong Pharmaceutical
Jiangsu Qihui
Sequent Scientific
K.A. Malle Pharmaceuticals
Lasa Supergenerics Limited
Zhongjia Pharmaceutical
Fredun Pharmaceuticals Ltd
Salius Pharma
Supharma Chem
Albendazole Product Segment Include:
Tablet
Capsule
Other
Albendazole Product Application Include:
Human
Veterinary
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Albendazole Industry PESTEL Analysis
Chapter 3: Global Albendazole Industry Porter's Five Forces Analysis
Chapter 4: Global Albendazole Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Albendazole Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Albendazole Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Albendazole Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Albendazole market size will reach 218.35 Million USD in 2025 and is projected to reach 379.58 Million USD by 2032, with a CAGR of 8.22% (2025-2032). Notably, the China Albendazole market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Albendazole is an anthelmintic medication used to treat a variety of parasitic worm infestations, including echinococcosis, cysticercosis, and neurocysticercosis. It works by preventing the worms from absorbing glucose, which ultimately leads to their death. Albendazole is available in tablet form and is commonly used in combination with other drugs for effective treatment.
The major global suppliers of Albendazole include GlaxoSmithKline, Huazhong Pharmaceutical, Jiangsu Qihui, Sequent Scientific, K.A. Malle Pharmaceuticals, Lasa Supergenerics Limited, Zhongjia Pharmaceutical, Fredun Pharmaceuticals Ltd, Salius Pharma, Supharma Chem, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Albendazole. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Albendazole market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Albendazole market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Albendazole industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Albendazole Include:
GlaxoSmithKline
Huazhong Pharmaceutical
Jiangsu Qihui
Sequent Scientific
K.A. Malle Pharmaceuticals
Lasa Supergenerics Limited
Zhongjia Pharmaceutical
Fredun Pharmaceuticals Ltd
Salius Pharma
Supharma Chem
Albendazole Product Segment Include:
Tablet
Capsule
Other
Albendazole Product Application Include:
Human
Veterinary
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Albendazole Industry PESTEL Analysis
Chapter 3: Global Albendazole Industry Porter's Five Forces Analysis
Chapter 4: Global Albendazole Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Albendazole Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Albendazole Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Albendazole Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Albendazole Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Albendazole Product by Type
- 1.2.1 Tablet
- 1.2.2 Capsule
- 1.2.3 Other
- 1.3 Albendazole Product by Application
- 1.3.1 Human
- 1.3.2 Veterinary
- 1.4 Global Albendazole Market Size Analysis (2020-2032)
- 1.5 Albendazole Market Development Status and Trends
- 1.5.1 Albendazole Industry Development Status Analysis
- 1.5.2 Albendazole Industry Development Trends Analysis
- 2 Albendazole Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Albendazole Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Albendazole Market Analysis by Country
- 4.1 Global Albendazole Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Albendazole Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Albendazole Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Albendazole Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Albendazole Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Albendazole Market Revenue and Growth Rate (2020-2032)
- 4.5 China Albendazole Market Revenue and Growth Rate (2020-2032)
- 4.6 France Albendazole Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Albendazole Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Albendazole Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Albendazole Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Albendazole Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Albendazole Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Albendazole Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Albendazole Market Revenue and Growth Rate (2020-2032)
- 4.14 India Albendazole Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Albendazole Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Albendazole Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Albendazole Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Albendazole Market Revenue by Key Suppliers (2021-2025)
- 5.2 Albendazole Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Albendazole Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Albendazole Market Analysis by Type
- 6.1 Global Albendazole Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Albendazole Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 GlaxoSmithKline
- 7.1.1 GlaxoSmithKline Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 GlaxoSmithKline Albendazole Product Portfolio
- 7.1.3 GlaxoSmithKline Albendazole Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Huazhong Pharmaceutical
- 7.2.1 Huazhong Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Huazhong Pharmaceutical Albendazole Product Portfolio
- 7.2.3 Huazhong Pharmaceutical Albendazole Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Jiangsu Qihui
- 7.3.1 Jiangsu Qihui Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Jiangsu Qihui Albendazole Product Portfolio
- 7.3.3 Jiangsu Qihui Albendazole Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Sequent Scientific
- 7.4.1 Sequent Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Sequent Scientific Albendazole Product Portfolio
- 7.4.3 Sequent Scientific Albendazole Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 K.A. Malle Pharmaceuticals
- 7.5.1 K.A. Malle Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 K.A. Malle Pharmaceuticals Albendazole Product Portfolio
- 7.5.3 K.A. Malle Pharmaceuticals Albendazole Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Lasa Supergenerics Limited
- 7.6.1 Lasa Supergenerics Limited Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Lasa Supergenerics Limited Albendazole Product Portfolio
- 7.6.3 Lasa Supergenerics Limited Albendazole Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Zhongjia Pharmaceutical
- 7.7.1 Zhongjia Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Zhongjia Pharmaceutical Albendazole Product Portfolio
- 7.7.3 Zhongjia Pharmaceutical Albendazole Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Fredun Pharmaceuticals Ltd
- 7.8.1 Fredun Pharmaceuticals Ltd Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Fredun Pharmaceuticals Ltd Albendazole Product Portfolio
- 7.8.3 Fredun Pharmaceuticals Ltd Albendazole Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Salius Pharma
- 7.9.1 Salius Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Salius Pharma Albendazole Product Portfolio
- 7.9.3 Salius Pharma Albendazole Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Supharma Chem
- 7.10.1 Supharma Chem Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Supharma Chem Albendazole Product Portfolio
- 7.10.3 Supharma Chem Albendazole Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Albendazole Industry Chain Analysis
- 8.2 Albendazole Product Downstream Application Analysis
- 8.2.1 Global Albendazole Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Albendazole Revenue and Forecast by Application (2020-2032)
- 8.3 Albendazole Typical Downstream Customers
- 8.4 Albendazole Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
